Jff. Pulsford et al., COMPARISON OF P-GLYCOPROTEIN EXPRESSION WITH IN-VITRO DRUG-SENSITIVITY IN FRESH BLAST CELLS FROM ACUTE MYELOID-LEUKEMIA PATIENTS, British journal of biomedical science, 52(3), 1995, pp. 188-194
Anthracyclines and etoposide have been implicated in the multi-drug re
sistance phenotype. The mdr 1 gene encodes for the transmembrane prote
in P-glycoprotein. P-glycoprotein expression was measured in the fresh
blast cells from 19 patients with acute myeloid leukaemia using three
monoclonal antibodies, C219, JSB-1 and MRK 16, and immunocytochemistr
y with the enzyme alkaline phosphatase as marker. Drug resistance can
be identified in vitro using the predictive chemosensitivity test, the
MTT (3-4,5-dimethylthiazol-2,5-diphenyl tetrazolium bromide) assay. I
n order to assess cell viability after drug exposure, this technique u
tilises the ability of cellular dehydrogenase enzymes to reduce the te
trazolium salt MTT to formazan. In vitro resistance to multi-drug resi
stance related cytotoxic agents was identified in the blast cells from
these patients. This study showed no correlation between the results
of the MTT assay and P-glycoprotein expression in this disease, sugges
ting either that more sensitive techniques are required to measure P-g
lycoprotein expression or that other drug resistance mechanisms may be
involved.